by Tyler Durden
It appears the crowd over at WallStreetBets may be as relentless as they are oblivious.
Shares of Clover Health - most recently known for plunging after noted short seller Hindenburg Research accused the company, and its resident advocate Chamath Palihapitiya, of failing to disclose a DOJ inquiry before going public - were up as much as 10% Monday morning on what appears to be a now-debunked notion that the company was sporting short interest that rivaled GameStop.
The company became a hot topic on Friday of last week, spiking 20% on the day to close the week, after S3 Partners - a company that is